Mice with homozygous or heterozygous TAL deficiency are predisposed to cirrhosis, hepatocellular carcinoma (HCC) and acetaminophen (APAP)‐induced liver failure. This evidence concerns the gene TALDO1 and hepatocellular carcinoma.